Page 2 - MyOwnSkin-Hensler 6_2020
P. 2
My O w n S k i n
T M
S p e c i fi c a t i o n G u i d e
Intended Uses
Plastic Surgery • Trauma • Burns • Ulcerations •
Cancerous Skin Removal • Scaffolding
Example Procedures
Mastectomies • C-Sections • Non-Healing Diabetic
Ulcers • 3rd Degree Burns
Product Description
MyOwn Skin is a unique biological technology, that
TM
is a painless, non-surgical procedure which leverages
a smal small sample of a patient’s own skin (1x1 cm), along with the patient’s blood, to produce as much
a
as three 100 cm of a patient’s own skin in seven days. The minimum order size for this product will
2
be one 5x5 cm sheet. MyOwn Skin is processed under FDA Regulation 361, which allows for a
TM
2
minimally manipulated autologous product.
Product Description
Fluid Flow liquid allograft is derived from the amniotic liquid within the placenta. It is rich in the
TM
growth factors and cytokines known to reduce inflammation, add an extra layer of microbial
protection, and promote angiogenisis.
Product Classification
MyOwn Skin is classified as a Skin Graft.
TM
Product Coding, Billing and Reimbursement
As a Skin Graft, existing CPT-Codes can be used for reimbursement (see our CPT-Coding Guide)
along with the Q-code for MyOwn Skin , Q4226.
TM
Sizes
$102 pe102 per squared centimeter with size options at 5x5 cm (25 cm) and 100cm (100 cm).
$
2
2
Product Benefits
Non-Invasive • No Operating Room Required • No Secondary Wound • Low Rejection Rate •
Painless • Fast • Non Surgical • Improved Recovery Time
©BioLab Sciences • 13825 N. Northsight Blvd. Suite 101, Scottsdale, AZ 85260 • 480-207-1884 • www.biolabsciences.net
